Share this page:
Investment Date | Original Shares | Original Value | Current Shares | Current Value | % Return | Split Adjustment | Current Price |
---|---|---|---|---|---|---|---|
Jan 30, 2014 | 1,000.00 | $46,000.00 | 1,000.00 | $24,640.00 | -46.43% | 1 | $24.64 |
Return calculations do not include reinvested cash dividends.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.